Heart Health in Type 2 Diabetes: In the evolving landscape of diabetes management, heart health in type 2 diabetes has emerged as one of the most critical areas of research and clinical focus. Beyond blood sugar control, new findings suggest that some diabetes medications do more than manage glucose—they can actually protect the heart. A…
CHEST 2025: Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that continues to remain widely underdiagnosed, despite its serious implications for lung and liver health. Individuals with AATD face an increased risk of developing chronic obstructive pulmonary disease (COPD), emphysema, and liver cirrhosis. The challenge in identifying affected individuals stems from the complexity of the…
Weight Loss Drugs: In a major breakthrough that could redefine how metabolic liver disease is treated, new research has revealed that weight loss drugs such as semaglutide and tirzepatide may do more than just help patients shed pounds—they could also significantly improve liver health. The findings offer fresh hope for millions of people suffering from…
